Accenture to Transform Diabetic Patient Care Using Data-driven Analytics Platform
July 26 2017 - 9:35AM
Business Wire
Accenture (NYSE: ACN) is collaborating with Roche (SIX: RO, ROG;
OTCQX: RHHBY) to improve how diabetes care is managed and delivered
through the development of a data-driven core analytics platform
for Roche’s digital diabetes ecosystem. The platform and ecosystem
will seamlessly connect patients, their caregivers and healthcare
providers with a suite of new digital health services.
Under the terms of a five-year agreement, Roche’s new digital
ecosystem and services will be built on the Accenture Intelligent
Patient Platform, and offered to diabetes patients across North
America, Europe and Asia. The open platform will provide Roche with
the ability to gather and analyze data in a secure environment,
generate new patient insights to provide more customized care, and
easily collaborate and integrate with its ecosystem partners and
devices used to manage diabetes care. The platform will integrate
all existing and future products, solutions and services.
“This collaboration agreement with Accenture is an exciting step
forward to offering truly integrated diabetes management
solutions,” said Marcel Gmünder, Global Head of Roche Diabetes
Care. “The open diabetes platform we are creating will enable us to
analyze large amounts of data through algorithms and put them into
context, respond faster to the needs of people with diabetes,
caregivers and healthcare systems and personalize treatment which
all-in-all can lead to improved outcomes. The collaboration builds
on the trusted relationship we have had over the years. It will
enable us to drive digital health in diabetes forward and offer
integrated diabetes management solutions and services to shape the
way care is being provided in the future, for improved therapy
outcomes and more sustainable healthcare systems.”
Andrea Brückner, who leads Accenture’s Life Sciences practice in
Europe, Africa, Middle East, and Latin America, said, “Uncontrolled
diabetes can lead to serious health problems but also bring about
substantial economic loss to those affected by the disease, through
direct medical costs and loss of work and wages. We are
collaborating with Roche to help combat this illness and increase
the management of secondary health problems by working to change
the standard of care and re-shaping the industry by seamlessly
connecting patients, caregivers and healthcare providers to share
information, data and insights to make better care decisions to
deliver more precise, personalized support.”
This collaboration with Roche is driven by Accenture’s
Intelligent Patient Services business, which is focused on enabling
life sciences clients to deliver patient outcomes by bringing
together strategic, analytic, and digital expertise to create
differentiated solutions and services. Learn more about the
Accenture Intelligent Patient Platform.
About Accenture
Accenture is a leading global professional services company,
providing a broad range of services and solutions in strategy,
consulting, digital, technology and operations. Combining unmatched
experience and specialized skills across more than 40 industries
and all business functions – underpinned by the world’s largest
delivery network – Accenture works at the intersection of business
and technology to help clients improve their performance and create
sustainable value for their stakeholders. With more than 411,000
people serving clients in more than 120 countries, Accenture drives
innovation to improve the way the world works and lives. Visit us
at www.accenture.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170726005707/en/
AccentureCam Granstra,
+1-312-693-5992cameria.l.granstra@accenture.com
Accenture (NYSE:ACN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Accenture (NYSE:ACN)
Historical Stock Chart
From Apr 2023 to Apr 2024